Funding for this research was provided by:
Advance Queensland (partnerships16-231, partnerships16-231, partnerships16-231)
Received: 11 December 2018
Accepted: 7 June 2019
First Online: 24 July 2019
Ethics approval and consent to participate
: Ethics approval for this case report was waived by the Metro North Hospital and Health Service Human Research Ethics Committee, in line with the Committee’s guidance for single case reports/quality improvement activities. Written consent to participate in this study was obtained from the subject patient.
: Written consent to publish case details was obtained from the subject patient.Availability of data and material.The datasets generated and/or analysed during the current study are either included in this article [and it’s supplementary information files], or available in the BioProject PRJNA494285 (ExternalRef removed), and on the Sequence Read Archive (ExternalRef removed) under the accession numbers (Illumina: SRR7957427; Nanopore: SRR7957428, complete genome: CP032681) and Cc_RBWH_01d (Illumina: SRR7957431)).
: SB, KH and LC hold a grant from the Queensland Government to explore MinION sequencing as a potential diagnostic tool. LC has received funding from Oxford Nanopore Technologies (ONT) to develop basecalling algorithms and to cover airfares and conference fees for an ONT community meeting. All other authors declare no competing interests. SB is a member of BMC Infectious Diseases Editorial Board.